Mario Paolo Colombo
Overview
Explore the profile of Mario Paolo Colombo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
1633
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bertolazzi G, Cancila V, Vacca D, Belmonte B, Lecis D, Moghaddam P, et al.
J Exp Clin Cancer Res
. 2025 Mar;
44(1):89.
PMID: 40065328
Background: The identification of molecular features characterizing metastatic disease is a critical area of oncology research, as metastatic foci often exhibit distinct biological behaviors compared to primary tumors. While the...
2.
Latarani M, Pucci P, Eccleston M, Manzo M, Gangadharannambiar P, Fischetti I, et al.
Epigenomics
. 2025 Jan;
17(3):145-154.
PMID: 39878501
Background: Aggressive Variant Prostate Cancers (AVPCs) are incurable malignancies. Platinum-based chemotherapies are used for the palliative treatment of AVPC. The Polycomb Repressive Complex 2 (PRC2) promotes prostate cancer progression histone...
3.
Bongiorno R, Lecchi M, Botti L, Bosco O, Ratti C, Fontanella E, et al.
Cell Death Dis
. 2024 Sep;
15(9):709.
PMID: 39349458
Breast cancer is the most frequent type of tumor in women and is characterized by variable outcomes due to its heterogeneity and the presence of many cancer cell-autonomous and -non-autonomous...
4.
Cancila V, Morello G, Bertolazzi G, Chan A, Bastianello G, Paysan D, et al.
Res Sq
. 2024 Apr;
PMID: 38562878
The germinal center (GC) dark zone (DZ) and light zone (LZ) regions spatially separate expansion and diversification from selection of antigen-specific B-cells to ensure antibody affinity maturation and B cell...
5.
Travelli C, Colombo G, Aliotta M, Fagiani F, Fava N, De Sanctis R, et al.
J Immunother Cancer
. 2023 Oct;
11(10).
PMID: 37880182
Background: Nicotinamide phosphoribosyltransferase (NAMPT) is a key intracellular enzyme that participates in nicotinamide adenine dinucleotide (NAD) homeostasis as well as a released cytokine (eNAMPT) that is elevated in inflammatory conditions...
6.
Bellone M, Brevi A, Bronte V, Dusi S, Ferrucci P, Nistico P, et al.
Cancer Immunol Immunother
. 2023 Mar;
72(7):2541-2548.
PMID: 36995489
No abstract available.
7.
Colciago R, Fischetti I, Giandini C, La Rocca E, Rancati T T, Rejas Mateo A, et al.
Expert Rev Anticancer Ther
. 2023 Feb;
23(2):135-145.
PMID: 36803369
Introduction: Oncological treatments are changing rapidly due to the advent of several targeted anticancer drugs and regimens. The primary new area of research in oncological medicine is the implementation of...
8.
Signorelli D, Ghidotti P, Proto C, Brambilla M, De Toma A, Ferrara R, et al.
Front Immunol
. 2022 Oct;
13:987639.
PMID: 36203609
PD-L1 in tumor cells is the only used biomarker for anti PD1/PD-L1 immune-checkpoints inhibitors (ICI) in Non Small Cell Lung Cancer (NSCLC) patients. However, this parameter is inaccurate to predict...
9.
Galli G, Corsetto P, Proto C, Lo Russo G, Ganzinelli M, Rulli E, et al.
Clin Lung Cancer
. 2022 Aug;
23(7):e489-e499.
PMID: 35948460
Introduction: Lipid metabolism impacts immune cell differentiation, activation, and functions, modulating inflammatory mediators, energy homeostasis, and cell membrane composition. Despite preclinical evidence, data in humans lack concerning tumors and immunotherapy...
10.
Corradi G, Bassani B, Simonetti G, Sangaletti S, Vadakekolathu J, Fontana M, et al.
Clin Cancer Res
. 2022 Mar;
28(14):3141-3155.
PMID: 35349670
Purpose: The stromal and immune bone marrow (BM) landscape is emerging as a crucial determinant for acute myeloid leukemia (AML). Regulatory T cells (Treg) are enriched in the AML microenvironment,...